MAPT and Alzheimer disease: It also interferes with protein kinase B (AKT)/glycogen synthase kinase-3 beta (GSK3β) signaling pathway, thereby exacerbating tau hyperphosphorylation at multiple residues and resulting in neuronal damage, which consequently accelerates the progression of AD 11.